Based on BMI, serum albumin, neutrophil, and lymphocyte counts, ALI was initially widely utilized to assess the prognosis of advanced lung cancer as a novel biomarker of nutritional inflammation (16, 51, 52). This evidence concerns the gene ALB and lung carcinoma.